Cargando…

Barriers to receiving hepatitis C treatment for people who inject drugs: Myths and evidence

BACKGROUND: Alcohol consumption, current injecting drug use, and pre-existing mental illness have been identified as 3 of the main reasons for excluding patients from treatment for hepatitis C. OBJECTIVES: We reviewed the literature to obtain an evidence base for these common exclusion criteria. MAT...

Descripción completa

Detalles Bibliográficos
Autores principales: Higgs, Peter, Sacks-Davis, Rachel, Gold, Judy, Hellard, Margaret
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212767/
https://www.ncbi.nlm.nih.gov/pubmed/22087188
_version_ 1782216020293844992
author Higgs, Peter
Sacks-Davis, Rachel
Gold, Judy
Hellard, Margaret
author_facet Higgs, Peter
Sacks-Davis, Rachel
Gold, Judy
Hellard, Margaret
author_sort Higgs, Peter
collection PubMed
description BACKGROUND: Alcohol consumption, current injecting drug use, and pre-existing mental illness have been identified as 3 of the main reasons for excluding patients from treatment for hepatitis C. OBJECTIVES: We reviewed the literature to obtain an evidence base for these common exclusion criteria. MATERIALS AND METHODS: We reviewed original research and meta-analyses investigating the effects of alcohol consumption, current injecting drug use, and pre-existing mental illness. RESULTS: We identified 66 study reports relevant to the review, but found only limited evidence to support withholding of treatment on the basis of the 3 previously mentioned exclusion criteria. CONCLUSIONS: Currently, there is a lack of evidence for many of the barriers faced by patients in availing treatment for hepatitis C. Adherence to treat routine was found to be a better predictor of sustained virological response than injecting drug or alcohol consumption during treatment period or the presence of a pre-existing mental disorder. Although several challenges remain, we need to ensure that treatment decisions are based on the best available evidence and the treatment is performed appropriately on a case-by-case basis.
format Online
Article
Text
id pubmed-3212767
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Kowsar
record_format MEDLINE/PubMed
spelling pubmed-32127672011-11-15 Barriers to receiving hepatitis C treatment for people who inject drugs: Myths and evidence Higgs, Peter Sacks-Davis, Rachel Gold, Judy Hellard, Margaret Hepat Mon Review Article BACKGROUND: Alcohol consumption, current injecting drug use, and pre-existing mental illness have been identified as 3 of the main reasons for excluding patients from treatment for hepatitis C. OBJECTIVES: We reviewed the literature to obtain an evidence base for these common exclusion criteria. MATERIALS AND METHODS: We reviewed original research and meta-analyses investigating the effects of alcohol consumption, current injecting drug use, and pre-existing mental illness. RESULTS: We identified 66 study reports relevant to the review, but found only limited evidence to support withholding of treatment on the basis of the 3 previously mentioned exclusion criteria. CONCLUSIONS: Currently, there is a lack of evidence for many of the barriers faced by patients in availing treatment for hepatitis C. Adherence to treat routine was found to be a better predictor of sustained virological response than injecting drug or alcohol consumption during treatment period or the presence of a pre-existing mental disorder. Although several challenges remain, we need to ensure that treatment decisions are based on the best available evidence and the treatment is performed appropriately on a case-by-case basis. Kowsar 2011-07-01 2011-07-01 /pmc/articles/PMC3212767/ /pubmed/22087188 Text en Copyright © 2011, Kowsar M.P. Co. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Higgs, Peter
Sacks-Davis, Rachel
Gold, Judy
Hellard, Margaret
Barriers to receiving hepatitis C treatment for people who inject drugs: Myths and evidence
title Barriers to receiving hepatitis C treatment for people who inject drugs: Myths and evidence
title_full Barriers to receiving hepatitis C treatment for people who inject drugs: Myths and evidence
title_fullStr Barriers to receiving hepatitis C treatment for people who inject drugs: Myths and evidence
title_full_unstemmed Barriers to receiving hepatitis C treatment for people who inject drugs: Myths and evidence
title_short Barriers to receiving hepatitis C treatment for people who inject drugs: Myths and evidence
title_sort barriers to receiving hepatitis c treatment for people who inject drugs: myths and evidence
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212767/
https://www.ncbi.nlm.nih.gov/pubmed/22087188
work_keys_str_mv AT higgspeter barrierstoreceivinghepatitisctreatmentforpeoplewhoinjectdrugsmythsandevidence
AT sacksdavisrachel barrierstoreceivinghepatitisctreatmentforpeoplewhoinjectdrugsmythsandevidence
AT goldjudy barrierstoreceivinghepatitisctreatmentforpeoplewhoinjectdrugsmythsandevidence
AT hellardmargaret barrierstoreceivinghepatitisctreatmentforpeoplewhoinjectdrugsmythsandevidence